{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:35:18Z","timestamp":1794105318863,"version":"4.8.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RG-1441-430"],"award-info":[{"award-number":["RG-1441-430"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113875","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:51:16Z","timestamp":1633009876000},"page":"113875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Binding site comparison for coumarin inhibitors and amine\/amino acid activators of human carbonic anhydrases"],"prefix":"10.1016","volume":"226","author":[{"given":"Andrea","family":"Petreni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-7301","authenticated-orcid":false,"given":"Sameh M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-9228","authenticated-orcid":false,"given":"Fatmah A.","family":"Alasmary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani M.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113875_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113875_bib2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113875_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113875_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113875_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature06636","article-title":"Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms","volume":"452","author":"Xu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113875_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/14756366.2020.1867122","article-title":"Anion inhibition studies of the Zn(II)-bound \u03b9-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii","volume":"36","author":"Petreni","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbapap.2009.08.026","article-title":"The gamma class of carbonic anhydrases","volume":"1804","author":"Ferry","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113875_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/bi802246s","article-title":"The archetype gamma-class carbonic anhydrase (Cam) contains iron when synthesized in\u00a0vivo","volume":"48","author":"Macauley","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113875_bib9","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1074\/jbc.M311648200","article-title":"A\u00a0role for iron in an ancient carbonic anhydrase","volume":"279","author":"Tripp","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2014.991312","article-title":"The \u03b7-class carbonic anhydrases as drug targets for antimalarial agents","volume":"19","author":"Supuran","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2021.113875_bib11","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113875_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expert Opin. Drug. Discov"},{"key":"10.1016\/j.ejmech.2021.113875_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.ejmech.2021.113875_bib15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113875_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-3565(24)29621-X","article-title":"Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats","volume":"297","author":"Sun","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113875_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuropharm.2017.03.009","article-title":"Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus","volume":"118","author":"Canto de Souza","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.113875_bib18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/14756366.2020.1766455","article-title":"Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders","volume":"35","author":"Blandina","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543776.2020.1811853","article-title":"Antibacterial carbonic anhydrase inhibitors: an update on the recent literature","volume":"30","author":"Supuran","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113875_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.113875_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013)","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113875_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113875_bib23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113875_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: a literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113875_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113875_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113875_bib27","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2021.113875_bib28","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","article-title":"A\u00a0class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects","volume":"23","author":"Carta","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic anhydrase inhibition and the management of neuropathic pain","volume":"16","author":"Supuran","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2021.113875_bib30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/14756366.2015.1113407","article-title":"Carbonic anhydrase inhibition for the management of cerebral ischemia: in\u00a0vivo evaluation of sulfonamide and coumarin inhibitors","volume":"31","author":"Di Cesare Mannelli","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib31","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib33","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/jm1003667","article-title":"Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule","volume":"53","author":"Temperini","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib34","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113875_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmc.2016.11.039","article-title":"Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/ijms20051208","article-title":"Novel 8-substituted coumarins that selectively inhibit human carbonic anhydrase IX and XII","volume":"20","author":"Buran","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113875_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","article-title":"Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase","volume":"36","author":"Nocentini","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib39","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib40","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/14756366.2020.1788009","article-title":"Coumarin carbonic anhydrase inhibitors from natural sources","volume":"35","author":"Supuran","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib41","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/molecules25071748","article-title":"Dual P-Glycoprotein and CA XII inhibitors: a new strategy to reverse the P-gp mediated multidrug resistance (MDR) in cancer cells","volume":"25","author":"Teodori","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113875_bib42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example","volume":"53","author":"Temperini","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib43","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","article-title":"Coumarins incorporating hydroxy- and chloro- moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113875_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C4CC07320G","article-title":"Out of the active site binding pocket for carbonic anhydrase inhibitors","volume":"51","author":"D'Ambrosio","year":"2015","journal-title":"Chem. Commun. (Camb)."},{"key":"10.1016\/j.ejmech.2021.113875_bib45","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.bmc.2012.07.021","article-title":"Natural product coumarins that inhibit human carbonic anhydrases","volume":"21","author":"Davis","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2021.113875_bib47","first-page":"411","article-title":"Carbonic anhydrase activators. Part 4. A general mechanism of action for activators of isozymes I, II and III","volume":"37","author":"Supuran","year":"1994","journal-title":"Rev. Roum. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jps.2600830603","article-title":"Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators","volume":"83","author":"Clare","year":"1994","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2021.113875_bib49","first-page":"107","article-title":"Carbonic anhydrase activators. Part 8. pKa - activation relationship in a series of amino acid derivatives activators of isozyme II","volume":"39","author":"Supuran","year":"1994","journal-title":"Rev. Roum. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib50","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1016\/j.bmcl.2006.05.023","article-title":"Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines","volume":"16","author":"Supuran","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113875_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4155\/fmc-2017-0223","article-title":"Carbonic anhydrase activators","volume":"10","author":"Supuran","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib52","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1021\/bi970760v","article-title":"Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine","volume":"36","author":"Briganti","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113875_bib53","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1002\/chem.200600159","article-title":"Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme","volume":"12","author":"Temperini","year":"2006","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2021.113875_bib54","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1016\/j.bmc.2008.08.043","article-title":"Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV","volume":"16","author":"Temperini","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib55","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/jm0603320","volume":"49","author":"Temperini","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib56","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bmcl.2006.11.027","article-title":"Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV","volume":"17","author":"Temperini","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113875_bib57","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1016\/j.bmcl.2005.08.069","article-title":"Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators","volume":"15","author":"Temperini","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113875_bib58","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1016\/j.bmcl.2006.07.021","article-title":"Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I","volume":"16","author":"Temperini","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113875_bib59","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1007\/s12035-017-0854-2","article-title":"Crystal structure of carbonic anhydrase II in complex with an activating ligand: implications in neuronal function","volume":"55","author":"Bhatt","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2021.113875_bib60","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1016\/j.bmcl.2011.06.030","article-title":"Carbonic anhydrase I and II activation with mono- and dihalogenated histamine derivatives","volume":"21","author":"Saada","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113875_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-6147(02)01899-0","article-title":"Carbonic anhydrase gating of attention: memory therapy and enhancement","volume":"23","author":"Sun","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113875_bib62","doi-asserted-by":"crossref","first-page":"16000","DOI":"10.1073\/pnas.1910690117","article-title":"The role of carbonic anhydrases in extinction of contextual fear memory","volume":"117","author":"Schmidt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.ejmech.2021.113875_bib63","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/14756366.2021.1891051","article-title":"Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives","volume":"36","author":"Provensi","year":"2021","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113875_bib64","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.3390\/ijms20194724","article-title":"A\u00a0new Kid on the block? Carbonic anhydrases as possible new targets in Alzheimer's disease","volume":"20","author":"Provensi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113875_bib65","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1002\/chem.201800941","article-title":"Deciphering the mechanism of human carbonic anhydrases inhibition with sulfocoumarins: computational and experimental studies","volume":"24","author":"Nocentini","year":"2018","journal-title":"Chemistry"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:39:02Z","timestamp":1759329542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":65,"alternative-id":["S0223523421007248"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113875","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding site comparison for coumarin inhibitors and amine\/amino acid activators of human carbonic anhydrases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113875"}}